This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Pancreatic Cysts Are Fluid-Filled Sacs That Can Form In The Pancreas. They Are Usually Benign And Asymptomatic, Meaning They Have No Symptoms. However, Some Pancreatic Cysts Can Be Cancerous. Pancreatic Cysts Can Be Divided Into Two Main Categories: Neoplastic (Cancerous) And Non-Neoplastic (Benign). The Most Common Type Of Non-Neoplastic Cyst Is A Pseudocyst, Which Is Caused By Inflammation Or Trauma To The Pancreas. The Second Most Common Type Of Cyst Is An Intraductal Papillary Mucinous Neoplasm (IPMN). These Are Non-Cancerous Cysts That Form In The Ducts Of The Pancreas. Most Pancreatic Cysts Are Benign And Require No Treatment. However, If The Cyst Is Causing Pain Or Other Symptoms, It May Need To Be Surgically Removed. Some Cysts Can Be Monitored With Imaging Tests, Such As CT Scans Or MRI Scans. If A Cyst Is Found To Be Cancerous, It Will Need To Be Surgically Removed Or Treated With Chemotherapy Or Radiation. Pancreatic Cysts Can Be Difficult To Diagnose Because They Often Do Not Cause Any Symptoms. If A Cyst Is Suspected, A Healthcare Professional May Order Imaging Tests, Such As A CT Scan Or An MRI Scan, To Confirm The Diagnosis. In Some Cases, A Biopsy May Be Needed To Determine If The Cyst Is Cancerous. Pancreatic Cysts Can Be A Cause For Concern, But Most Are Benign And Do Not Require Any Treatment. If A Cyst Is Suspected, It Is Important To Get It Checked Out By A Healthcare Professional To Determine If It Is Cancerous And If Any Treatment Is Needed.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States